Trial intelligence / Profile preview

Effects of stopping chronic benzodiazepine, Z-hypnotic, or opioid use on driving and balance

NL-OMON44190Phase 4Active, not recruiting

Sponsor
Maastricht University
Start
Apr 2018
Countries
1
01

Overview

Phase 4, open-label trial in pain (2 arms), sponsored by Maastricht University. Primary endpoint: Standard deviation of lateral position. Started Apr 2018; status: active, not recruiting.

02

Conditions

pain

Beyond the preview

Go deeper on NL-OMON44190.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON44190.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call